Published On:March 27 2014
Story Viewed 1538 Times

Caplin Point Laboratories spurts after commencement of commercial production at a plant.

Caplin Point Laboratories was locked at 5% upper circuit at Rs. 175.50 on BSE after the company said that its state-of-art injectable plant near Gummidipoondi, Tamil Nadu has commenced its commercial production on, 27 March 2014.

BS


OUR OTHER PRODUCTS & SERVICES: Projects Database | Tenders Database | About Us | Contact Us | Terms of Use | Advertise with Us | Privacy Policy | Disclaimer | Feedback

This site is best viewed with a resolution of 1024x768 (or higher) and supports Microsoft Internet Explorer 4.0 (or higher)
Copyright © 2016-2026

Technology Partner - Pairscript Software